Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Travere Therapeutics, Inc. | 129,165 | reported | 21 Nov 2014 | tx 7+70,665 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 Nov 2014 | PURCHASE | Travere Therapeutics, Inc. | 6,100 | 8.38 USD | first after silence |
| 06 Nov 2014 | GRANT_AWARD | Travere Therapeutics, Inc. | 20,000 | 0.00 USD | |
| 06 Nov 2014 | GRANT_AWARD | Travere Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 15 Aug 2013 | PURCHASE | Travere Therapeutics, Inc. | 1,110 | 4.50 USD | |
| 06 Dec 2013 | GRANT_AWARD | Travere Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 15 Aug 2013 | PURCHASE | Travere Therapeutics, Inc. | 555 | — | deriv |
| 05 Nov 2013 | PURCHASE | Travere Therapeutics, Inc. | 2,900 | 6.90 USD |
1 purchase reported after at least 12 months of silence — most recent on 21 Nov 2014.